Category: Medical
-
STAT+: States might not get cheaper drugs in Trump’s most-favored nation Medicaid pilot program
•
WASHINGTON — When President Trump announced the administration’s deal to cut prices for weight-loss drugs, he proclaimed that “you…
-
STAT+: FDA broadens search for new top drug regulator after early setbacks
•
WASHINGTON — The Food and Drug Administration is struggling to select a new head of its drug center after…
-
STAT+: Up and down the ladder: The latest comings and goings
•
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with…
-
STAT+: Patient with liver damage in Intellia trial dies
•
This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get…
-
STAT+: Pharmalittle: We’re reading about a Trump deal on obesity meds, a Medicaid drug-price pilot, and more
•
And so, another working week will soon draw to a close. Not a moment too soon, yes? This…
-
STAT+: Why one expert thinks Gilead can produce a $25 HIV prevention shot, help eradicate the disease in the U.S.
•
For the past few months, CVS Caremark has declined to add a groundbreaking HIV prevention drug from Gilead…
-
STAT+: Kennedy, a longtime pharma critic, embraces Trump deal to expand access to obesity drugs
•
WASHINGTON — Health Secretary Robert F. Kennedy Jr. was uncharacteristically chummy with pharma executives at the White House on…
-
STAT+: Seven burning questions about Trump’s big deal for cheaper weight loss drugs
•
WASHINGTON — The Trump administration’s deal to expand access to and lower the cost of weight loss drugs…
-
STAT+: FDA announces next round of priority review vouchers
•
WASHINGTON — The Food and Drug Administration on Thursday announced the second batch of companies being granted a “Commissioner’s…
-
STAT+: Mark Cuban is trying to shake up biosimilar pricing with a version of J&J’s best-selling Stelara drug
•
In its latest bid to shake up the prescription drug market, the Mark Cuban Cost Plus Drug Company…
-
STAT+: Trump announces deal with Lilly, Novo to expand access to weight loss drugs, cut prices
•
WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…
-
STAT+: Pharmalittle: We’re reading about the Pfizer-Novo battle for Metsera, a Lilly obesity drug, and more
•
Top of the morning to you, and a fine one it is. Despite howling winds lashing the Pharmalot…
-
STAT+: A bet on baldness
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-
STAT+: FDA approves J&J’s antipsychotic drug to treat depression
•
Johnson & Johnson won U.S. approval to sell the antipsychotic drug Caplyta as a treatment for depression, the…
-
STAT+: FTC raises concern about Novo Nordisk attempt to acquire obesity startup Metsera
•
The Federal Trade Commission has raised concerns about Novo Nordisk’s attempt to outbid Pfizer to acquire obesity startup…
-
STAT+: Pfizer’s view on the Metsera bidding war
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement
